S. Challenor

Contrasting approaches to end of life and palliative care in end stage kidney disease

R. Fassett, R. Bull, A. Koshy, 2012, Indian journal of nephrology.

Palliative care in end‐stage kidney disease

R. Fassett, R. Bull, I. Robertson, 2011, Nephrology.

Results of a United Kingdom real-world study of polatuzumab vedotin, bendamustine, and rituximab for relapsed/refractory DLBCL

C. Burton, A. Davies, P. McKay, 2022, Blood advances.

Routine HIV and sexually transmitted infection testing in an abortion service: 6 years’ experience

R. Challenor, S. Challenor, H. Gregson, 2016, Journal of Family Planning and Reproductive Health Care.

SARS‐CoV‐2‐induced remission of Hodgkin lymphoma

S. Challenor, D. Tucker, 2021, British journal of haematology.

Pathways to palliative care for patients with chronic kidney disease.

R. Fassett, R. Bull, I. Robertson, 2014, Journal of renal care.

Diagnostic uncertainty presented barriers to the timely management of acute thrombotic thrombocytopenic purpura in the United Kingdom between 2014 and 2019

Quentin M. Hill, R. Buka, G. Benson, 2022, Journal of thrombosis and haemostasis : JTH.

POLATUZUMAB VEDOTIN WITH BENDAMUSTINE AND RITUXIMAB FOR RELAPSED/REFRACTORY HIGH‐GRADE B‐CELL LYMPHOMA: THE UK EXPERIENCE

W. Wilson, C. Burton, P. McKay, 2021, Hematological Oncology.